Article Dans Une Revue Journal of Clinical Medicine Année : 2021

Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group

Pierre Collinet
Marcos Ballester
  • Fonction : Auteur
  • PersonId : 1077600
  • IdRef : 092189806
Lobna Ouldamer
Yohann Dabi
Emilie Raimond
  • Fonction : Auteur
  • PersonId : 1085064
Alexandre Bricou

Résumé

To determine if the time-to-chemotherapy (TTC) after primary macroscopic complete cytoreductive surgery (CRS) influences recurrence-free survival (RFS) and overall survival (OS) in patients with epithelial ovarian cancer (EOC). We conducted an observational multicenter retrospective cohort analysis of women with EOC treated from September 2006 to November 2016 in nine institutions in France (FRANCOGYN research group) with maintained EOC databases. We included women with EOC (all FIGO stages) who underwent primary complete macroscopic CRS prior to platinum-based adjuvant chemotherapy. Two hundred thirty-three patients were included: 73 (31.3%) in the early-stage group (ESG) (FIGO I-II), and 160 (68.7%) in the advanced-stage group (ASG) (FIGO III-IV). Median TTC was 43 days (36–56). The median OS was 77.2 months (65.9–106.6). OS was lower in the ASG when TTC exceeded 8 weeks (70.5 vs. 59.3 months, p = 0.04). No impact on OS was found when TTC was below or above 6 weeks (78.5 and 66.8 months, respectively, p = 0.25). In the whole population, TTC had no impact on RFS or OS. None of the factors studied were associated with an increase in TTC. Chemotherapy should be initiated as soon as possible after CRS. A TTC greater than 8 weeks is associated with poorer OS in patients with advanced stage EOC.
Fichier principal
Vignette du fichier
jcm-10-01058-v2.pdf (1.73 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03163298 , version 1 (09-03-2021)

Identifiants

Citer

Grégoire Rocher, Thomas Gaillard, Catherine Uzan, Pierre Collinet, Pierre-Adrien Bolze, et al.. Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group. Journal of Clinical Medicine, 2021, 10 (5), pp.1058. ⟨10.3390/jcm10051058⟩. ⟨hal-03163298⟩
103 Consultations
55 Téléchargements

Altmetric

Partager

More